Dissecting MHC class II export, B cell maturation, and DM stability defeets in invariant chain mutant mice

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3271-3280

  Koonce, Chad H ^a   Bikoff, Elizabeth K ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HLA DM ANTIGEN; INVARIANT CHAIN PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN P31; PROTEIN P41; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; COMPARATIVE STUDY; GENETIC STABILITY; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION;

EID: 4344682542     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3271     Document Type: Article

References (117)

1. Goldrath, A. W., and M. J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402:255.
2. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
3. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
4. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
5. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18:113.
6. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
7. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegb, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
8. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
9. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, repertoire selection. Cell 84:543.
10. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
11. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
12. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
13. Rovere, P., V. S. Zimmermann, F. Forquet, D. Demandolx, J. Trucy, P. Ricciardi-Castagnoli, and J. Davoust. 1998. Dendritic cell maturation and antigen presentation in the absence of invariant chain. Proc. Natl. Acad Sci. USA 95:1067.
14. Wolf, P. R., S. Toume, T. Miyazaki, C. Benoist, D. Mathis, and H. L. Ploegh. 1998. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur. J. Immunol. 28:2605.
15. + T cells in the periphery and secondary proliferative responses elicited upon peptide challenge. J. Immunol. 163:232.
16. + T cell maturation in BALB/c mice. J. Immunol. 166:5087.
17. Koonce, C. H., G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff. 2003. DM loss in k haplotype mice reveals isotype-specific chaperone requirements. J. Immunol. 170:3751.
18. Ting, J. P., and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109(Suppl):S21.
19. Mastemak, K., and W. Reith. 2002. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation. EMBO J. 21:1379.
20. Nekrep, N., J. D. Fontes, M. Geyer, and B. M. Peterlin. 2003. When the lymphocyte loses its clothes. Immunity 18:453.
21. Pierre, P., and I. Mellman. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93:1135.
22. Villadangos, J. A., M. Cardoso, R. J. Steptoe, D. van Berkel, J. Pooley, F. R. Carbone, and K. Shortman. 2001. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14:739.
23. Trombetta, E. S., M. Ebersold, W. Garrett, M. Pypaert, and I. Mellman. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299:1400.
24. Schaiff, W. T., K. A. Hruska, Jr., D. W. McCourt, M. Green, and B. D. Schwatlz. 1992. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176:657.
25. Anderson, K. S., and P. Cresswell. 1994. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13:675.
26. Bonnerot, C., M. S. Marks, P. Cosson, E. J. Robertson, E. K. Bikoff, R. N. Germain, and J. S. Bonifacino. 1994. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13:934.
27. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
28. Lotteau, V. L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. L. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600.
29. Teyton, L., D. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways, Nature 348:39.
30. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
31. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
32. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
33. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.
34. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
35. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hammerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15:6144.
36. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
37. Kropshofer, H., S. O. Arndt, G. Moldenhauer, G. J. Hammerling and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293.
38. Karlsson, L., A. Peleraux, R. Lindstedt, M. Liljedahl, and P. A. Peterson. 1994. Reconstitution of an operational MHC class II compartment in nonandgen-presenting cells. Science 266:1569.
39. Marks, M. S., P. A. Roche, E. van Donselaar, L. Woodruff, P. J. Peters, and J. S. Bonifacino. 1995. A lysosomal targeting signal in the cytoplasmic tail of the chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131:351.
40. Lindstedt, R., M. Liljedahl, A. Peleraux, P. A. Peterson, and L. Karlsson. 1995. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3:561.
41. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106.
42. Kenty, G., W. D. Martin, L. Van Kaer, and E. K. Bikoff. 1998. MHC class II expression in double mutant mice lacking invariant chain and DM functions. J. Immunol. 160:606.
43. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
44. Markowitz, J. S., P. R. Rogers, M. J. Grusby, D. C. Parker, and L. H. Glimcher. 1993. B lymphocyte development and activation independent of MHC class II expression. J. Immunol. 150:1223.
45. Rolink, A. G., T. Brocker, H. Bluethmann, M. H. Kosco-Vilbois, J. Andersson, and F. Melchers. 1999. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 10:619.
46. Gilfillan, S., S. Aiso, S. A. Michie, and H. O. McDevitt. 1990. Immune deficiency due to high copy numbers of an Ak β transgene. Proc. Natl. Acad. Sci. USA 87:7319.
47. Gilfillan, S., S. Aiso, D. Smilek, D. L. Woodland, E. Palmer, and H. O. McDevitt. 1991. An immune response defect due to low levels of class II cell surface expression: analysis of antigen presentation and positive selection. J. Immunol. 147:4074.
48. Singer, S. M., D. T. Umetsu, and H. O. McDevitt. 1996. High copy number I-Ab transgenes induce production of IgE through an interleukin 4-dependent mechanism. Proc. Natl. Acad. Sci. USA 93:2947.
49. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA 96:10338.
50. Labrecque, N., L. Madsen, L. Fugger, C. Benoist, and D. Mathis. 1999. Toxic MHC class II β chains. Immunity 11:515.
51. Matza, D., O. Wolstein, R. Dikstein, and I. Shachar. 2001. Invariant chain induces B cell maturation by activating a TAF(II) 105-NF-κB- dependent transcription program. J. Biol. Chem. 276:27203.
52. Matza, D., F. Lantner, Y. Bogoch, L. Flaishon, R. Hershkoviz, and I. Shachar. 2002. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc. Natl. Acad. Sci. USA 99:3018.
53. Matza, D., A. Kerem, H. Medvedovsky, F. Lantner, and I. Shachar. 2002. Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain. Immunity 17:549.
54. Castellino, F., R. Han, and R. N. Germain. 2001. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31:841.
55. Kaufman, R. J. 1999. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13:1211.
56. Kaufman, R. J., D. Scheuner, M. Schroder, X. Shen, K. Lee, C. Y. Liu, and S. M. Arnold. 2002. The unfolded protein response in nutrient sensing and differentiation. Nat. Rev. Mol. Cell. Biol. 3:411.
57. Sitia, R., and I. Braakman. 2003. Quality control in the endoplasmic reticalum protein factory. Nature 426:891.
58. Stem, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465.
59. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
60. Marks, M. S., R. N. Germain, and J. S. Bonifacino. 1995. Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells. J. Biol. Chem. 270:10475.
61. Shachar, I., E. A. Elliott, B. Chasnoff, I. S. Grewal, and R. A. Flavell. 1995. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms. Immunity 3:373.
62. Goldberg, A. L. 2003. Protein degradation and protection against misfolded of damaged proteins. Nature 426:895.
63. DusseIjee, S., R. Wubbolts, D. Verwoerd, A. Tulp, H. Janssen, J. Calafat, and J. Neefjes. 1998. Removal and degradation of the free MHC class II β chain in the endoplasmic reticulum requires proteasomes and is accelerated by BFA. J. Cell Sci. 111:2217.
64. Zhu, L., and P. P. Jones. 1990. Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes. Mol. Cell. Biol. 10:3906.
65. Brown, A. M., M. W. Linhoff, B. Stein, K. L. Wright, A. S. Baldwin, Jr., P. V. Basta, and J. P. Ting. 1994. Function of NF-κB/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-KB/Rel subunits. Mol. Cell. Biol. 14:2926.
66. Radley, E., R. P. Alderton, A. Kelly, J. Trowsdale, and S. Beck. 1994. Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex. J. Biol. Chem. 269:18834.
67. Westerheide, S. D., P. Louis-Plence, D. Ping, X. F. He, and J. M. Boss. 1997. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158:4812.
68. Kontgen, F., G. Suss, C. Stewart, M. Steinmetz, and H. Bluethmann. 1993. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 5:957.
69. + T cell function in mice lacking the p41 isoform of invariant chain. Immunity 3:385.
70. Takaesu, N. T., J. A. Lower, D. Yelon, E. J. Robertson, and E. K. Bikoff. 1997. In vivo functions mediated by the p41 isoform of the MHC class II-associated invariant chain. J. Immunol. 158:187.
71. Tourne, S., H. M. van Santen, M. van Roon, A. Berns, C. Benoist, D. Mathis, and H. Ploegh. 1996. Biosynthesis of major histocompatibility complex molecules and generation of T cells in Ii TAP1 double-mutant mice. Proc. Natl. Acad. Sci. USA 93:1464.
72. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
73. McCluskey, J., J. A. Bluestone, J. E. Coligan, W. L. Maloy, and D. H. Margulies. 1986. Serologic and T cell recognition of truncated transplantation antigens encoded by in vitro deleted class I major histocompatibility genes. J. Immunol. 136:1472.
74. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse, Annu. Rev. Immunol. 13:179.
75. Carrasco-Marin, E., J. Shimizu, O. Kanagawa, and E. R. Unanue. 1996. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
76. Reizis, B., M. Eisenstein, J. Bockova, S. Konen-Waisman, F. Mor, D. Elias, and I. R. Cohen. 1997. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int. Immunol. 9:43.
77. Peterson, M., and A. J. Sant. 1998. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. J. Immunol. 161:2961.
78. Hausmann, D. H., B. Yu, S. Hausmann, and K. W. Wucherpfennig. 1999. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189:1723.
79. Serreze, D. V., H. D. Chapman, D. S. Vamum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig μ null mice. J. Exp. Med. 184:2049.
80. Pierre, P., I. Shachar, D. Matza, E. Gatti, R. A. Flavell, and I. Mellman. 2000. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells. J. Exp. Med. 191:1057.
81. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
82. Sha, W. C. 1998. Regulation of immune responses by NF-κB/Rel transcription factor. J. Exp. Med. 187:143.
83. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81.
84. Benlagha, K., S. H. Park, R. Guinamard, C. Forestier, L. Karlsson, C. H. Chang, and A. Bendelac. 2004. Mechanisms governing B cell developmental defects in invariant chain-deficient mice. J. Immunol. 172:2076.
85. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603.
86. Zhong, G., P. Romagnoli, and R. N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocyfic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429.
87. Marks, M. S., J. S. Blum, and P. Cresswell. 1990. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111:839.
88. Kearney, J. F., M. D. Cooper, J. Klein, E. R. Abney, R. M. Parkhouse, and A. R. Lawton. 1977. Ontogeny of Ia and IgD, on IgM-bearing B lymphocytes in mice. J. Exp. Med. 146:297.
89. Mond, J. J., E. Seghal, J. Kung, and F. D. Finkelman. 1981. Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J. Immunol. 127:881.
90. Chen, Z. Z., J. C. McGuire, K. L. Leach, and J. C. Cambier. 1987. Transmembrane signaling through B cell MHC class II molecules: anti-Ia antibodies induce protein kinase C translocation to the nuclear fraction. J. Immunol. 138:2345.
91. Wade, W. F., Z. Z. Chen, R. Maki, S. McKercher, E. Palmer, J. C. Cambier, and J. H. Freed. 1989. Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein. Proc. Natl. Acad. Sci. USA 86:6297.
92. Nabavi, N., Z. Ghogawala, A. Myer, I. J. Griffith, W. F. Wade, Z. Z. Chen, D. J. McKean, and L. H. Glimcher. 1989. Antigen presentation abrogated in cells expressing truncated Ia molecules. J. Immunol. 142:1444.
93. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
94. Newell, M. K., J. VanderWall, K. S. Beard, and J. H. Freed. 1993. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc. Natl. Acad. Sci. USA 90:10459.
95. Andre, P., J. C. Cambier, T. K. Wade, T. Raetz, and W. F. Wade. 1994. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules. J. Exp. Med. 179:763.
96. Harton, J. A., A. E. Van Hagen, and G. A. Bishop. 1995. The cytoplasmic and transmembrane domains of MHC class II β chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 3:349.
97. Rich, T., S. E. Lawler, J. M. Lord, V. M. Blancheteau, D. J. Charron, and N. A. Mooney. 1997. HLA class II-induced translocation of PKC α and PKC β II isoforms is abrogated following truncation of DR β cytoplasmic domains. J. Immunol. 159:3792.
98. Leverkus, M., A. D. McLellan, M. Heldmann, A. O. Eggert, E. B. Brocker, N. Koch, and E. Kampgen. 2003. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int. Immunol. 15:993.
99. Smiley, S. T., T. M. Laufer, D. Lo, L. H. Glimcher, and M. J. Grusby. 1995. Transgenic mice expressing MHC class II molecules with truncated A β cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int. Immunol. 7:665.
100. Smiley, S. T., A. Y. Rudensky, L. H. Glimcher, and M. J. Grusby. 1996. Truncation of the class II β-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes. Proc. Natl. Acad. Sci. USA 93:241.
101. Lang, P., J. C. Stolpa, B. A. Freiberg, F. Crawford, J. Kappler, A. Kupfer, and J. C. Cambier. 2001. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-α/β dimers. Science 291:1537.
102. Reth, M. 1992. Antigen receptors on B lymphocytes. Annu. Rev. Immunol. 10:97.
103. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751.
104. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284.
105. Katz, J. F., C. Stebbins, E. Appella, and A. J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747.
106. Lightstone, L., R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler. 1997. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence of absence of HLA-DM. Proc. Natl. Acad. Sci. USA 94:5772.
107. Gonzalez, A., J. D. Katz, M. G. Mattei, H. Kikutani, C. Benoist, and D. Mathis. 1997. Genetic control of diabetes progression. Immunity. 7:873.
108. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoinumme diabetes in nonobese diabetic mice. J. Immunol. 161:3912.
109. Weaver, D. J., Jr., B. Poligone, T. Bui, U. M. Abdel-Motal, A. S. Baldwin, Jr., and R. Tisch. 2001. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κB regulation due to a hyperactive IκB kinase. J. Immunol. 167:1461.
110. Poligone, B., D. J. Weaver, Jr., P. Sen, A. S. Baldwin, Jr., and R. Tisch. 2002. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168:188.
111. Liu, J., and D. I. Beller. 2003. Distinct pathways for NF-κB regulation are associated with aberrant macrophage II-12 production in lupus- and diabetesprone mouse strains. J. Immunol. 170:4489.
112. Fremont, D. H., F. Crawford, P. Marrack, W. A. Hendrickson, and J. Kappler. 1998. Crystal structure of mouse H2-M. Immunity 9:385.
113. Mosyak, L., D. M. Zaller, and D. C. Wiley. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377.
114. Han, R. 1997. Impact of a truncated invariant chain on in vitro assembly of class II MHC molecules depends on the affinity of invariant chain for a given αβ dimer. Immunol. Invest. 26:421.
115. Wilson, N. A., P. Wolf, H. Ploegh, L. Ignatowicz, J. Kappler, and P. Marrack. 1998. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161:4777.
116. Weber, D. A., C. T. Dao, J. Jun, J. L. Wigal, and P. E. Jensen. 2001. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J. Immunol. 167:5167.
117. Silveira, P. A., J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172:5086.